From September 15, 2023 to September 30, 2023, the company has repurchased 730,578 shares, representing 0.18% for CNY 25.2 million. With this, the company has completed the repurchase of 730,578 shares, representing 0.18% for CNY 25.2 million under the buyback announced on September 18, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.97 CNY | -0.79% |
|
+3.63% | -26.27% |
Jul. 02 | Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on March 12, 2024. | CI |
May. 20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.27% | 1.37B | |
+7.40% | 101B | |
+7.76% | 42.18B | |
-13.60% | 32.26B | |
+80.99% | 29.79B | |
-12.03% | 16.06B | |
+2.12% | 14.45B | |
-6.77% | 12.01B | |
+182.74% | 10.71B | |
+4.64% | 8.89B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on September 18, 2023.